Ovid Therapeutics/$OVID
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ovid Therapeutics
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Ticker
$OVID
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
23
ISIN
US6904691010
Website
OVID Metrics
BasicAdvanced
$21M
-
-$0.34
0.27
-
Price and volume
Market cap
$21M
Beta
0.27
52-week high
$1.31
52-week low
$0.24
Average daily volume
766K
Financial strength
Current ratio
4.934
Quick ratio
4.62
Long term debt to equity
22.049
Total debt to equity
24.344
Interest coverage (TTM)
-64.02%
Profitability
EBITDA (TTM)
-52.9
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-4,557.30%
Operating margin (TTM)
-9,766.06%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-31.37%
Return on equity (TTM)
-36.31%
Valuation
Price to revenue (TTM)
38.334
Price to book
0.35
Price to tangible book (TTM)
0.36
Price to free cash flow (TTM)
-0.423
Free cash flow yield (TTM)
-236.57%
Free cash flow per share (TTM)
-70.00%
Growth
Revenue change (TTM)
15.61%
Earnings per share change (TTM)
-51.33%
3-year revenue growth (CAGR)
-27.62%
3-year earnings per share growth (CAGR)
-29.63%
What the Analysts think about OVID
Analyst ratings (Buy, Hold, Sell) for Ovid Therapeutics stock.
OVID Financial Performance
Revenues and expenses
OVID Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ovid Therapeutics stock?
Ovid Therapeutics (OVID) has a market cap of $21M as of June 21, 2025.
What is the P/E ratio for Ovid Therapeutics stock?
The price to earnings (P/E) ratio for Ovid Therapeutics (OVID) stock is 0 as of June 21, 2025.
Does Ovid Therapeutics stock pay dividends?
No, Ovid Therapeutics (OVID) stock does not pay dividends to its shareholders as of June 21, 2025.
When is the next Ovid Therapeutics dividend payment date?
Ovid Therapeutics (OVID) stock does not pay dividends to its shareholders.
What is the beta indicator for Ovid Therapeutics?
Ovid Therapeutics (OVID) has a beta rating of 0.27. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.